HF
HZNP

HRT Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

HRT Financial’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-134,760
Closed -$15.6M – 3384
2023
Q3 		$15.6M Buy
134,760
+81,028
+151% +$8.71M 0.16% 82
2023
Q2 		$5.53M Buy
+53,732
New +$5.67M 0.05% 260
2023
Q1 		– Sell
-105,637
Closed -$12M – 3624
2022
Q4 		$12M Buy
105,637
+88,282
+509% +$7.33M 0.17% 109
2022
Q3 		$1.07M Buy
+17,355
New +$1.21M 0.01% 867
2022
Q2 		– Sell
-36,257
Closed -$3.81M – 4129
2022
Q1 		$3.81M Buy
+36,257
New +$3.53M 0.03% 365
2021
Q4 		– Sell
-68,116
Closed -$7.46M – 4545
2021
Q3 		$7.46M Sell
68,116
-51,128
-43% -$5.31M 0.05% 220
2021
Q2 		$11.2M Buy
119,244
+113,471
+1,966% +$10.4M 0.1% 170
2021
Q1 		$531K Sell
5,773
-17,739
-75% -$1.5M 0.01% 1727
2020
Q4 		$1.72M Sell
23,512
-276,812
-92% -$20.6M 0.03% 371
2020
Q3 		$23.3M Buy
+300,324
New +$20.7M 0.68% 26
2019
Q3 		– Sell
-163,059
Closed -$3.92M – 1712
2019
Q2 		$3.92M Buy
+163,059
New +$4.14M 0.25% 95

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HRT Financial's HZNP Position: Q4 2023 in Review

HRT Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 134,760 shares — an estimated $15.6M sold.

HRT Financial first reported a position in HZNP in Q2 2019 and held it in 11 quarters. The position peaked at $23.3M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • HRT Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 134,760 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $15.6M.
  • HRT Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 11 quarters.
  • HRT Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $23.3M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.